1 / 13

LabOnStrip

Strictly Confidential. LabOnStrip. User-Friendly and Cost-Effective Medical Diagnostic Packaging System Investor Presentation June 2005. What is LabOnStrip ?. LabOnStrip is a: Packaging concept “ Zero-step ” diagnostic kit Activation mechanism Entire packaging system

evelia
Download Presentation

LabOnStrip

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Strictly Confidential LabOnStrip User-Friendly and Cost-Effective Medical Diagnostic Packaging System Investor Presentation June 2005

  2. What is LabOnStrip? LabOnStrip is a: • Packaging concept • “Zero-step” diagnostic kit • Activation mechanism • Entire packaging system …which provides: • Convenience • Handy packaging formats and sizes • Ease of use

  3. What is LabOnStrip’s Mission? • To commercialize the LabOnStrip concept… • … in collaboration with major diagnostics companies, to… • … create a major new diagnostic kit packaging-system industry

  4. What is the Opportunity? • Medical diagnostics is a steady high-growth sector: • Always looking for innovation • Trend: “More convenience…ease of use” • Demand for “latest” products • Proprietary products: • IP strategy • Patents for products • Patents for manufacturing system • What can be achieved: • Proprietary ownership of complete packaging system technology • Penetration into existing markets • Creation of new market categories

  5. The Technology • Core Concept • Fabrication using lamination • Reagents sealed in capsules • Release-mechanism • Integral liquid paths • “Virtual test tube” • Flexibility of System • Different Tests • Multiple stages • Reagent combinations • Result read-out • Packaging Formats • Credit-card (face) • Broad card

  6. Advantages • General Advantages: • Convenience • Low-cost • Ease of use • Consistent reagent doses • Suitable for clinic or home • Advantages for Strep A field: • High-end item in terms of convenience • Every card is independent • High-quality printing area for instructions • Easy to handle, store and dispose

  7. Engineering and Manufacturing • Exploitation of existing facilities: • Based on existing, proven technology (licensed from Timestrip) • Use of prototyping lab at Pantogram • Manufacturing technology: • Mass-production machinery proven and in use for Timestrip product • Pilot machine in Y2 • Full scale production machine for first JV / OEM deal

  8. Market • Overview: • Market size - $15.5B for all medical diagnostics • For Strep A – conservative estimate is $312m • Competitive factors– ease of use, accuracy, cost • Market Approach: • Market via existing channels • OEM or JV relationship with partner • Retain rights for additional applications of technology

  9. Business Model • LabOnStrip is technology-platform company • Will hold patents and trademarks • Specializes in manufacturing technology • Supports JVs • Controls business strategy • Joint-Ventures (JVs) can be established for specific markets where: • LabOnStrip owns shares in JV in return for technology license • JV partner brings finance and market access • Advance from JVs provides ongoing finance to LabOnStrip • Potential JVs / OEM relationships: • Strep A diagnostic kit • Other medical diagnostics • Non-medical applications

  10. Investment and Return • Q1-Q3: Prototype design and proving, machinery estimates, full BP - samples delivered,$240K • Q4: First strategic investment, partner / investors brings $3-5m in finance • Y3: First JV enters production • Y4:“Exits” commence • From JVs • From LabOnStrip LabOnStrip JVs / OEM relationship Markets Strategic Partners

  11. Current Status • Technical: • Technology licensed from Timestrip • Basic design of “card” performed • Material compatibility-testing started • Subcontractors identified • Business: • Potential applications reviewed • Initial application specified: Strep A • Additional applications include diagnostic kits for mononucleosis, HIV and cancer markers; and water testing. • Marketing partners identified.

  12. The LabOnStripTeam Amir Genosar Medical Device Specialist Ian Solomon Business Development Gideon Kahana CEO Nili Tamir Dir. Marketing Ilan Schragenheim Dir. Development • Proven management team, experienced in: • medical diagnostics • the packaging industry • developing innovative technologies • IP strategy • venture creation • “exit” realization • industrial cooperation

  13. LabOnStrip– Value Proposition • Proprietary system • Proven base technology • High-profit category • Low initial investment • Multiple “exit” points • Multiple applications

More Related